Home Cart 0 Sign in  
X

[ CAS No. 6933-47-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 6933-47-7
Chemical Structure| 6933-47-7
Chemical Structure| 6933-47-7
Structure of 6933-47-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6933-47-7 ]

Related Doc. of [ 6933-47-7 ]

Alternatived Products of [ 6933-47-7 ]

Product Details of [ 6933-47-7 ]

CAS No. :6933-47-7 MDL No. :MFCD08458829
Formula : C9H11NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :NRTWXBXJSGGTTE-UHFFFAOYSA-N
M.W : 165.19 Pubchem ID :11672721
Synonyms :

Calculated chemistry of [ 6933-47-7 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.09
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.77
Log Po/w (XLOGP3) : 1.47
Log Po/w (WLOGP) : 1.37
Log Po/w (MLOGP) : 1.64
Log Po/w (SILICOS-IT) : 1.44
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.03
Solubility : 1.55 mg/ml ; 0.00937 mol/l
Class : Soluble
Log S (Ali) : -2.18
Solubility : 1.1 mg/ml ; 0.00668 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.49
Solubility : 0.531 mg/ml ; 0.00321 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.25

Safety of [ 6933-47-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6933-47-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6933-47-7 ]
  • Downstream synthetic route of [ 6933-47-7 ]

[ 6933-47-7 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 6933-47-7 ]
  • [ 103440-53-5 ]
Reference: [1] Patent: WO2010/10184, 2010, A1, . Location in patent: Page/Page column 80; 81
  • 2
  • [ 6933-47-7 ]
  • [ 103261-67-2 ]
YieldReaction ConditionsOperation in experiment
59% With hydrogenchloride; sodium carbonate; sodium nitrite In water at 0 - 100℃; for 19 h; Methyl 4-amino-2-methylbenzoate (1 ) (4.14 g, 25.1 mmol) was suspended in cone. HCI (20 ml.) and H20 (100 ml.) and stirred at 0°C. A solution of sodium nitrite (1 .73 g, 25.1 mmol) in H20 (50 ml.) was slowly added to the suspension such that the (0587) temperature was maintained at 0-5°C. The mixture was made basic by the addition of aq. Na2C03 and added dropwise to a stirring mixture of potassium cyanide (1 .88 g, (0588) 28.8 mmol) and copper (I) cyanide (2.58 g, 28.8 mmol) in H20 (200 ml.) at 0-5°C. The mixture was stirred at 0-5°C for 0.5 h, then was warmed to RT and stirred for 18 h. The mixture was stirred at 100°C for 0.5 h and then cooled to RT and treated with 10percent aq. FeC solution (250 ml_). The product was extracted with EtOAc (600 ml.) and the organic solution was washed with brine (500 ml_), dried over Na2S04, filtered and concentrated in vacuo. The product was purified by silica gel chromatography (120 g cartridge, 0-10percent EtOAc in isohexane) to afford a red solid. The product was recrystallised from isohexane/EtOAc to give the title compound (2) (2.58 g, 59percent) as an orange solid: 1 H NMR (400 MHz, CDCI3) δ: 7.97 (1 H, dd), 7.58 - 7.50 (2H, m), 3.93 (3H, s), 2.62 (3H, s)
Reference: [1] Patent: WO2016/97004, 2016, A1, . Location in patent: Page/Page column 69; 70
  • 3
  • [ 62621-09-4 ]
  • [ 6933-47-7 ]
YieldReaction ConditionsOperation in experiment
100% With ammonium formate In ethanol at 40℃; for 2 h; Intermediate 7; Methyl 4-amino-2-methylbenzoate; To a solution of methyl 2-methyl-4-nitrobenzoate (Intermediate 5) (3.25 g, 16.6 mmol) in ethanol was added Pd/C 10percent (catalytic quantity) and ammonium formate (10.5 g, 0.17 mmol). The mixture was stirred at 400C for 2 hours. The mixture was filtered on celite, washed with diethyl ether. The filtrate was evaporated and the residue was diluted with diethyl ether, washed with water. The organic phase was dried over Na2SC>4, filtered and evaporated to give the title compound as brown oil (2.8 g, quantitative yield). NMR1H NMR (300 MHz), CDCI3 δ: 7.74 (d, 1 H, J=9.20 Hz), 6.41 (m, 2H), 3.75 (s, 3H), 2.47 (s, 3H).
Reference: [1] Patent: WO2009/47240, 2009, A1, . Location in patent: Page/Page column 29
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 942 - 945
[3] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 946 - 949
[4] Bulletin de la Societe Scientifique de Bretagne, 1956, vol. 31, p. Sonderheft S.9,41
[5] Patent: WO2006/7542, 2006, A1, . Location in patent: Page/Page column 24
  • 4
  • [ 67-56-1 ]
  • [ 103204-69-9 ]
  • [ 6933-47-7 ]
YieldReaction ConditionsOperation in experiment
94%
Stage #1: for 3 h; Reflux
Stage #2: With sodium hydroxide In waterCooling with ice
4-Acetamido-2-methylbenzoic acid (46 g, 238 mmol) is initially charged in methanol (460 ml), and concentrated sulphuric acid (63 g, 643 mmol) is added. The reaction mixture is heated under reflux for 3 h, cooled, carefully added to ice-water and made alkaline using 5N aqueous sodium hydroxide solution. Extraction with ethyl acetate, drying of the organic phase over sodium sulphate and removal of the solvent under reduced pressure gives ethyl 4-amino-2-methylbenzoate (38.3 g, 232 mmol, 94percent) which is used without further purification for the next step.
Reference: [1] Patent: WO2006/89909, 2006, A1, . Location in patent: Page/Page column 99
[2] Patent: US2011/190365, 2011, A1, . Location in patent: Page/Page column 28
[3] Patent: WO2005/111014, 2005, A1, . Location in patent: Page/Page column 156-157
[4] Patent: WO2011/92140, 2011, A1, . Location in patent: Page/Page column 76
[5] Patent: US2012/28938, 2012, A1, . Location in patent: Page/Page column 44
  • 5
  • [ 67-56-1 ]
  • [ 2486-75-1 ]
  • [ 6933-47-7 ]
YieldReaction ConditionsOperation in experiment
85% With hydrogenchloride In waterReflux Step 1.
Synthesis of methyl 4-amino-2-methylbenzoate
To a solution of 4-amino-2-methylbenzoic acid (1.00 g, 6.60 mmol) in 18 mL of methanol was treated concentrated HCl (2.30 mL, 27.6 mmol) in one portion at r.t.
The reaction mixture was refluxed overnight then directly concentrated to give a crude product, which was partitioned between ethyl acetate (50 mL) and saturated NaHCO3(aq) (20 mL).
The organic layer was washed with brine (10 mL), dried over MgSO4 and concentrated to give the desired product (930 mg, 85percent).
1H NMR (CDCl3, 400 MHz) δ 7.83-7.80 (m, 1H), 6.51-6.48 (m, 2H), 4.15 (br s, 2H), 3.83 (s, 3H), 2.55 (s, 3H).
Reference: [1] Patent: US2017/253569, 2017, A1, . Location in patent: Paragraph 0175-0176
  • 6
  • [ 91133-71-0 ]
  • [ 6933-47-7 ]
Reference: [1] Patent: WO2006/64286, 2006, A1, . Location in patent: Page/Page column 117
[2] Patent: WO2007/144379, 2007, A1, . Location in patent: Page/Page column 46
  • 7
  • [ 6933-47-7 ]
  • [ 672293-33-3 ]
YieldReaction ConditionsOperation in experiment
85% With sodium periodate; iodine In N,N-dimethyl-formamide at 50℃; for 2 h; Intermediate 9; methyl 4-amino-5-iodo-2-methylbenzoate; To a solution of methyl 4-amino-2-methylbenzoate (Intermediate 7) (2.9 g, 16.6 mmol) in DMF (15 ml) was added sodium periodate (1.45 g, 6.6 mmol) and iodine (3.4 g, 13.3 mmol). The reaction mixture was stirred at 500C for 2 hours. The mixture was poured into cold water with NaHSO3 (0.5 g). After stirring, the mixture was left overnight. The precipitate was filtered, washed with water and diluted with dichloromethane. This solution was dried over Na2SO4, filtered and evaporated to give the title compound as orange solid (4.1 g, 85percent). NMR1H NMR (300 MHz), CDCI3 δ: 8.20 (s, 1 H), 6.47 (s, 1 H), 3.75 (s, 3H), 2.42 (s, 3H).
65%
Stage #1: With sodium periodate; iodine In N,N-dimethyl-formamide at 50℃; for 3 h;
Stage #2: With sodium hydrogen sulfite In water; N,N-dimethyl-formamide for 3 h;
To a mixture of 136   methyl 4-amino-2-methylbenzoate (15.0 g, 85.86 mmol) in 30   DMF (80 mL) was added 137   sodium periodate (7.36 g, 34.42 mmol) and 138   iodine (17.6. g, 68.84 mmol). The reaction mixture was stirred at 50° C. for 3 hours. The mixture was poured into a solution of 139   NaHSO3 (2.6 g) in 86   water (200 mL). After stirring for 3 h, the mixture was extracted with DCM (300 mL×3). The organic layer was dried over sodium sulfate, concentrated under reduced pressure and purified by chromatography on silica gel (2percent-30percent 32   EtOAc in 60   pet. ether) to give 18A (16.15 g, 65percent yield) as a yellow 140   solid: 1H NMR (400 MHz, CDCl3) δ 8.20 (s, 1H), 6.47 (s, 1H), 3.75 (s, 3H), 2.42 (s, 3H) ; ESI m/z 292.0 [M+H]+
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 942 - 945
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 3, p. 946 - 949
[3] Patent: WO2009/47240, 2009, A1, . Location in patent: Page/Page column 30
[4] Patent: US2018/291002, 2018, A1, . Location in patent: Paragraph 0462; 0463
[5] Patent: US2004/142940, 2004, A1, . Location in patent: Page/Page column 42
[6] Patent: WO2006/7542, 2006, A1, . Location in patent: Page/Page column 24
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6933-47-7 ]

Aryls

Chemical Structure| 619-45-4

[ 619-45-4 ]

Methyl 4-aminobenzoate

Similarity: 0.98

Chemical Structure| 1312425-07-2

[ 1312425-07-2 ]

3-Amino-5-(ethoxycarbonyl)benzoic acid

Similarity: 0.96

Chemical Structure| 18595-18-1

[ 18595-18-1 ]

Methyl 3-amino-4-methylbenzoate

Similarity: 0.94

Chemical Structure| 79909-92-5

[ 79909-92-5 ]

Methyl 4-amino-2,6-dimethylbenzoate

Similarity: 0.94

Chemical Structure| 18595-16-9

[ 18595-16-9 ]

Methyl 2-amino-5-methylbenzoate

Similarity: 0.94

Esters

Chemical Structure| 619-45-4

[ 619-45-4 ]

Methyl 4-aminobenzoate

Similarity: 0.98

Chemical Structure| 1312425-07-2

[ 1312425-07-2 ]

3-Amino-5-(ethoxycarbonyl)benzoic acid

Similarity: 0.96

Chemical Structure| 18595-18-1

[ 18595-18-1 ]

Methyl 3-amino-4-methylbenzoate

Similarity: 0.94

Chemical Structure| 79909-92-5

[ 79909-92-5 ]

Methyl 4-amino-2,6-dimethylbenzoate

Similarity: 0.94

Chemical Structure| 65399-05-5

[ 65399-05-5 ]

5-Aminophthalide

Similarity: 0.94

Amines

Chemical Structure| 619-45-4

[ 619-45-4 ]

Methyl 4-aminobenzoate

Similarity: 0.98

Chemical Structure| 1312425-07-2

[ 1312425-07-2 ]

3-Amino-5-(ethoxycarbonyl)benzoic acid

Similarity: 0.96

Chemical Structure| 18595-18-1

[ 18595-18-1 ]

Methyl 3-amino-4-methylbenzoate

Similarity: 0.94

Chemical Structure| 79909-92-5

[ 79909-92-5 ]

Methyl 4-amino-2,6-dimethylbenzoate

Similarity: 0.94

Chemical Structure| 65399-05-5

[ 65399-05-5 ]

5-Aminophthalide

Similarity: 0.94